BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23035964)

  • 1. Gadolinium MRI contrast agents based on triazine dendrimers: relaxivity and in vivo pharmacokinetics.
    Lim J; Turkbey B; Bernardo M; Bryant LH; Garzoni M; Pavan GM; Nakajima T; Choyke PL; Simanek EE; Kobayashi H
    Bioconjug Chem; 2012 Nov; 23(11):2291-9. PubMed ID: 23035964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of MRI properties between derivatized DTPA and DOTA gadolinium-dendrimer conjugates.
    Nwe K; Bernardo M; Regino CA; Williams M; Brechbiel MW
    Bioorg Med Chem; 2010 Aug; 18(16):5925-31. PubMed ID: 20663676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dendrimer-based MRI contrast agents: the effects of PEGylation on relaxivity and pharmacokinetics.
    Kojima C; Turkbey B; Ogawa M; Bernardo M; Regino CA; Bryant LH; Choyke PL; Kono K; Kobayashi H
    Nanomedicine; 2011 Dec; 7(6):1001-8. PubMed ID: 21515406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of novel macrocyclic and acyclic ligands as contrast enhancement agents for magnetic resonance imaging.
    Chong HS; Garmestani K; Bryant LH; Milenic DE; Overstreet T; Birch N; Le T; Brady ED; Brechbiel MW
    J Med Chem; 2006 Mar; 49(6):2055-62. PubMed ID: 16539394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation, characterization and in vivo assessment of Gd-albumin and Gd-dendrimer conjugates as intravascular contrast-enhancing agents for MRI.
    Nwe K; Milenic D; Bryant LH; Regino CA; Brechbiel MW
    J Inorg Biochem; 2011 May; 105(5):722-7. PubMed ID: 21463567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and Relaxometric Characterization of New Poly[N,N-bis(3-aminopropyl)glycine] (PAPGly) Dendrons Gd-Based Contrast Agents and Their in Vivo Study by Using the Dynamic Contrast-Enhanced MRI Technique at Low Field (1 T).
    Granato L; Longo D; Boutry S; Vander Elst L; Henoumont C; Aime S; Muller RN; Laurent S
    Chem Biodivers; 2019 Nov; 16(11):e1900322. PubMed ID: 31544357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of nanoglobular macrocyclic Mn(II) chelate conjugates as non-gadolinium(III) MRI contrast agents.
    Tan M; Ye Z; Jeong EK; Wu X; Parker DL; Lu ZR
    Bioconjug Chem; 2011 May; 22(5):931-7. PubMed ID: 21473650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macromolecular MRI contrast agents with small dendrimers: pharmacokinetic differences between sizes and cores.
    Kobayashi H; Kawamoto S; Jo SK; Bryant HL; Brechbiel MW; Star RA
    Bioconjug Chem; 2003; 14(2):388-94. PubMed ID: 12643749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polyion complex micelle MRI contrast agents from poly(ethylene glycol)-b-poly(l-lysine) block copolymers having Gd-DOTA; preparations and their control of T(1)-relaxivities and blood circulation characteristics.
    Shiraishi K; Kawano K; Maitani Y; Yokoyama M
    J Control Release; 2010 Dec; 148(2):160-7. PubMed ID: 20804796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The relaxivity of Gd-EOB-DTPA and Gd-DTPA in liver and kidney of the Wistar rat.
    Shuter B; Tofts PS; Wang SC; Pope JM
    Magn Reson Imaging; 1996; 14(3):243-53. PubMed ID: 8725190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macromolecular and dendrimer-based magnetic resonance contrast agents.
    Bumb A; Brechbiel MW; Choyke P
    Acta Radiol; 2010 Sep; 51(7):751-67. PubMed ID: 20590365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo comparative performance studies of gadolinium-loaded zeolites and Gd-DOTA as contrast agents for MRI applications.
    Contro J; Silva DA; Santisteban OAN; Narayana PA; Nery JG
    J Biomed Mater Res B Appl Biomater; 2021 Aug; 109(8):1105-1115. PubMed ID: 33283412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Physical, chemical and biological evaluations of CMD-A2-Gd-DOTA. A new paramagnetic dextran polymer.
    Corot C; Schaefer M; Beauté S; Bourrinet P; Zehaf S; Bénizé V; Sabatou M; Meyer D
    Acta Radiol Suppl; 1997; 412():91-9. PubMed ID: 9240087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
    Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
    Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cyclen-based Gd
    Rashid HU; Martines MAU; Jorge J; de Moraes PM; Umar MN; Khan K; Rehman HU
    Bioorg Med Chem; 2016 Nov; 24(22):5663-5684. PubMed ID: 27729196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.
    Luo K; Liu G; She W; Wang Q; Wang G; He B; Ai H; Gong Q; Song B; Gu Z
    Biomaterials; 2011 Nov; 32(31):7951-60. PubMed ID: 21784511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of a phosphodiester linking group on albumin binding, blood half-life, and relaxivity of intravascular diethylenetriaminepentaacetato aquo gadolinium(III) MRI contrast agents.
    McMurry TJ; Parmelee DJ; Sajiki H; Scott DM; Ouellet HS; Walovitch RC; Tyeklár Z; Dumas S; Bernard P; Nadler S; Midelfort K; Greenfield M; Troughton J; Lauffer RB
    J Med Chem; 2002 Aug; 45(16):3465-74. PubMed ID: 12139457
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.